Professional China Pharma Ingredients - Genistein – Chenlv Detail:
CAS Number:446-72-0
Appearance: white fine powder
Test method: HPLC
Molecular Formula: C15H10O5
Molecular Weight:270.241
Specification: 98%
An isoflavonoid derived from soy products. It inhibits protein-tyrosine kinase and topoisomerase-II (DNA topoisomerases, type II) activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 phase arrest in human and murine cell lines.
Additionally, genistein has antihelmintic activity. It has been determined to be the active ingredient in Felmingia vestita, which is a plant traditionally used against worms. It has shown to be effective in the treatment of common liver fluke, pork trematode and poultry cestode.
Further, genistein is a phytoestrogen which has selective estrogen receptor modulator properties. It has been investigated in clinical trials as an alternative to classical hormone therapy to help prevent cardiovascular disease in postmenopausal women 1.
Natural sources of genistein include tofu, fava beans, soybeans, kudzu, and lupin.
Product packing: 25kg/drum
Validity period: 2 years
Product detail pictures:
Related Product Guide:
We have been ready to share our knowledge of internet marketing worldwide and recommend you suitable merchandise at most aggressive rates. So Profi Tools present you very best price of money and we are ready to develop alongside one another with Professional China Pharma Ingredients - Genistein – Chenlv, The product will supply to all over the world, such as: Amsterdam , Munich , Malawi , we rely on own advantages to build a mutual-benefit commerce mechanism with our cooperative partners. As a result, we have gained a global sales network reaching the Middle East, Turkey, Malaysia and Vietnamese.
By Jacqueline from The Swiss - 2018.12.11 11:26
The factory has advanced equipment, experienced staffs and good management level, so product quality had assurance, this cooperation is very relaxed and happy!
By Hellyngton Sato from Greece - 2018.09.21 11:01